Logo image of NOM

NUVEEN MO QLTY MUNI INC (NOM) Stock Overview

NYSE:NOM - US67060Q1085

10.875 USD
-0.08 (-0.69%)
Last: 8/26/2025, 8:04:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NOM. NOM was compared to 0 industry peers in the Unkown industry. NOM has a bad profitability rating. Also its financial health evaluation is rather negative. NOM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NOM had negative earnings in the past year.
NOM had a positive operating cash flow in the past year.
In multiple years NOM reported negative net income over the last 5 years.
Of the past 5 years NOM 4 years had a positive operating cash flow.
NOM Yearly Net Income VS EBIT VS OCF VS FCFNOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M

1.2 Ratios

Industry RankSector Rank
ROA -1.69%
ROE -2.96%
ROIC 1.22%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOM Yearly ROA, ROE, ROICNOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10

1.3 Margins

NOM's Operating Margin has declined in the last couple of years.
NOM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 32.99%
PM (TTM) N/A
GM 36.08%
OM growth 3Y-19.91%
OM growth 5Y-10.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.03%
GM growth 5Y-9.39%
NOM Yearly Profit, Operating, Gross MarginsNOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for NOM remains at a similar level compared to 5 years ago.
NOM Yearly Shares OutstandingNOM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 500K 1M 1.5M 2M
NOM Yearly Total Debt VS Total AssetsNOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M 40M 50M

2.2 Solvency

NOM has an Altman-Z score of 0.77. This is a bad value and indicates that NOM is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of NOM is 4.58, which is a neutral value as it means it would take NOM, 4.58 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.71 indicates that NOM is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 4.58
Altman-Z 0.77
ROIC/WACCN/A
WACCN/A
NOM Yearly LT Debt VS Equity VS FCFNOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.69 indicates that NOM may have some problems paying its short term obligations.
NOM has a Quick Ratio of 0.69. This is a bad value and indicates that NOM is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69
NOM Yearly Current Assets VS Current LiabilitesNOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

NOM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -183.33%.
NOM shows a decrease in Revenue. In the last year, the revenue decreased by -0.20%.
Measured over the past years, NOM shows a decrease in Revenue. The Revenue has been decreasing by -0.80% on average per year.
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-816.67%
Revenue 1Y (TTM)-0.2%
Revenue growth 3Y2.7%
Revenue growth 5Y-0.8%
Sales Q2Q%-2.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NOM Yearly Revenue VS EstimatesNOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOM Price Earnings VS Forward Price EarningsNOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.89
EV/EBITDA N/A
NOM Per share dataNOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

NOM has a Yearly Dividend Yield of 6.76%, which is a nice return.
NOM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 6.76%

5.2 History

NOM has paid a dividend for at least 10 years, which is a reliable track record.
NOM has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NOM Yearly Dividends per shareNOM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

NOM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-257.75%
EPS Next 2YN/A
EPS Next 3YN/A
NOM Yearly Income VS Free CF VS DividendNOM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M

More info and screens

NUVEEN MO QLTY MUNI INC

NYSE:NOM (8/26/2025, 8:04:01 PM)

10.875

-0.08 (-0.69%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners10.9%
Inst Owner Change-1.23%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap25.56M
Analysts0
Price TargetN/A
Short Float %0.15%
Short Ratio0.6
Dividend
Industry RankSector Rank
Dividend Yield 6.76%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-257.75%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-15 2025-08-15 (0.0675)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.17
P/FCF 6.89
P/OCF 6.89
P/B 1.06
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.58
FCFY14.52%
OCF(TTM)1.58
OCFY14.52%
SpS0.83
BVpS10.21
TBVpS10.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.69%
ROE -2.96%
ROCE 1.55%
ROIC 1.22%
ROICexc 1.22%
ROICexgc 1.22%
OM 32.99%
PM (TTM) N/A
GM 36.08%
FCFM 191.24%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-14.58%
ROICexcg growth 5Y-7.69%
ROICexc growth 3Y-14.58%
ROICexc growth 5Y-7.69%
OM growth 3Y-19.91%
OM growth 5Y-10.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.03%
GM growth 5Y-9.39%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 4.58
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.82
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z 0.77
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-816.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.2%
Revenue growth 3Y2.7%
Revenue growth 5Y-0.8%
Sales Q2Q%-2.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.86%
EBIT growth 3Y-17.75%
EBIT growth 5Y-11.21%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y762.79%
FCF growth 3Y20.13%
FCF growth 5Y23.33%
OCF growth 1Y762.79%
OCF growth 3Y20.13%
OCF growth 5Y23.33%